Fiche publication
Date publication
octobre 2022
Journal
Healthcare (Basel, Switzerland)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane
,
Pr CHENUEL Bruno
,
Pr POUSSEL Mathias
Tous les auteurs :
Allado E, Poussel M, Hamroun A, Moussu A, Kneizeh G, Hily O, Temperelli M, Corradi C, Koch A, Albuisson E, Chenuel B
Lien Pubmed
Résumé
Following COVID-19 infection, many patients suffer from long-lasting symptoms that may greatly impair their quality of life. Persisting dyspnea and other functional respiratory complaints can evoke hyperventilation syndrome (HVS) as a putative contributor to long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between HVS and previous acute COVID-19 infection. We designed a cross-sectional, single-center study, including all patients consecutively referred to our Lung Function and Exercise Testing Department between January and June 2021. Participants completed a systematic Nijmegen Questionnaire, a modified Medical Research Council dyspnea scale assessment, a post-COVID screening questionnaire, and performed a standardized lung function test. The population was divided according to HVS diagnosis, defined as a Nijmegen score of > 23/64. The occurrence of previous COVID-19 infection was compared according to the Nijmegen score after adjustment for potential confounders by multivariate logistic regression. In total, 2846 patients were included: 1472 men (51.7%) with a mean age of 56 (±16.6) years. A total of 455 patients (16%) declared a previous SARS-CoV-2 infection, and 590 patients presented a positive score (>23/64) in the Nijmegen Questionnaire (20.7%). Compared with COVID-19-free patients, there was an increased occurrence of HVS+ in cases of COVID-19 infection that did not require hospitalization (aOR = 1.93 [1.17-3.18]). The results of this large-scale, cross-sectional study suggest an association between HVS diagnosis and a history of COVID-19 disease in patients who were not hospitalized.
Mots clés
COVID-19, hyperventilation, long COVID
Référence
Healthcare (Basel). 2022 10 28;10(11):